Shortening the pharmaceutical development lifecycle and reducing costs with IBM Clinical Development®
Costs, overheard and time spent are factors Biorasi strives to reduce for its partners in complex clinical trials. IBM is the leading healthcare technology organization in the world. Recently, they wrote a case study on how Biorasi was able to remove the obstacles and optimize its efforts in running clinical trials. As one o the first adopters of the IBM Watson Health technology, Biorasi continues to demonstrate the effectiveness of innovation within clinical trials around the globe.